Avania will evolve, invest, and pivot with the industry so it can achieve its mission of partnering with MedTech sponsors to bring life-changing technology to market, resulting in improved healthcare ...

Implementing child-resistant and senior-friendly blister packaging is essential for pharmacies to enhance safety and accessibility. Such packaging significantly reduces the risk of accidental ...

Acquisition of new generation extended-dwell catheter and patented insertion system strengthens Vygon’s vascular access leadership and accelerates US expansion Vygon, a leading group specialized in ...

The laboratory is one of the most critical parts of patient care. Behind every result is a sequence of people, instruments, and systems working in sync. The LIS software is the engine that keeps all ...

Through a unique combination of sample-locking architecture, passive media exchange, and imaging-grade optics, the VitroPrime™ 3D Culture and Imaging Plate addresses persistent challenges in 3D cell ...

FDA Breakthrough-designated device under evaluation for treatment of life-threatening abdominal bleeding at leading U.S. trauma centers shows promising results in first patient Arsenal Medical, a ...

Ezra Viewer gives patients a new way to interact with their MRI data and digest their results. Ezra, the NY-based startup transforming early cancer screening using full-body MRI scans, today announced ...

Luxury amenities in rehab centers are not just about grandeur; they serve a therapeutic purpose. A serene and aesthetically pleasing environment can significantly reduce stress, a known relapse ...

Guido Baechler, CEO of Mainz Biomed: “Securing the exclusive rights to license this portfolio of novel biomarkers is a major milestone and extension of our previously announced PancAlert program. It ...

This new clearance builds on version 3 of LungQ®, cleared by the FDA last year, which introduced advanced lung segmentation capabilities - a critical foundation for accurate analysis on a regional ...

Eric Sauter, COO and Co-Founder for Atraverse Medical, commented, "Our mission is to improve efficiency and take the guesswork out of what should be simply-executed therapeutic and diagnostic ...

In 2024, CAR T cell therapy can cost anywhere between $500,000 and $1 million per patient, predominantly because of the steep expense that existing manufacturing processes like magnets and columns ...